Stakeholders seek clarity in FDA’s AI in regulatory decision-making draft guidance
Regulatory NewsFerdous Al-Faruque
Artificial intelligence/machine learning (AI/ML)Biologics/ biosimilars/ vaccinesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)